Metraipolis › archive › dc_6d181a97555f
Advancing precision immuno-oncology in melanoma: the synergistic convergence of personalized neoantigen vaccines and multi-omics biomarker profiling — Europe PMC PMID:42136652
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42136652
- DOI
- 10.3389/fimmu.2026.1831047
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T02:49:44.683Z
- SHA-256 of the archived text
73c184913cf588141f3b9234330ec88d4e52c37b0fc902e1b5c815a46cdff45c- Stable URL of this page
https://metraipolis.com/documento/dc_6d181a97555f
How to cite
Advancing precision immuno-oncology in melanoma: the synergistic convergence of personalized neoantigen vaccines and multi-omics biomarker profiling — Europe PMC PMID:42136652 — Europe PMC (en), https://europepmc.org/article/MED/42136652 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6d181a97555f (Metraipolis archive dc_6d181a97555f, sha256 73c184913cf588141f3b9234330ec88d4e52c37b0fc902e1b5c815a46cdff45c)
BibTeX
@misc{dc6d181a97555f,
title = {Advancing precision immuno-oncology in melanoma: the synergistic convergence of personalized neoantigen vaccines and multi-omics biomarker profiling — Europe PMC PMID:42136652},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42136652},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6d181a97555f; sha256 73c184913cf588141f3b9234330ec88d4e52c37b0fc902e1b5c815a46cdff45c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42136652. Agents can read the archived copy with the MCP tool read_document.